May. 12 at 12:51 PM
$ADGM
Earnings out earlier than usual.
Cash burn under control.
BofA Conference presentation tomorrow.
CEO’s comments on next 6 months:
“As we look ahead, we have multiple additional meaningful milestones expected this year across our platform of technologies and we are more confident than ever in our mission to fundamentally change the treatment of VT with a safe, effective solution for a broad group of patients who suffer from this dangerous arrhythmia."